OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
3199$1380.0057

Watahan & Co Ltd

Food Retail & DistributionVerified

Watahan maintains a capital structure with a debt-to-equity ratio of 1.15, indicating moderate leverage relative to equity. The company's liquidity position is characterized by a current ratio of 1.26, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of 1.93 billion JPY supports operational flexibility, though operating cash flow is negative at -2.88 billion JPY, signaling potential working capital constraints. Profitability metrics show a return on equity of 8.94% and a return on assets of 2.62%, both below the typical thresholds for high-performing retailers. The company's operating margin is 2.15% (2.87 billion JPY operating income on 133.59 billion JPY revenue), which is weak compared to industry peers. Gross margin of 21.0% (28.03 billion JPY gross profit) is in line with the sector median, but the low operating margin suggests high operating expenses or pricing pressures. Geographically, Watahan's revenue is concentrated in Japan, with no disclosed international operations. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or customer bases. This concentration increases exposure to domestic economic shifts and regulatory changes. The company's growth trajectory is modest, with revenue of 133.59 billion JPY in the latest period. No forward-looking guidance is provided, but the current price-to-earnings ratio of 12.41 and price-to-book of 1.11 suggest a valuation in line with industry norms. The enterprise value to EBITDA of 16.93 is also consistent with the sector average, indicating a stable but not aggressive growth profile. Risk factors include a negative net cash position after subtracting total debt, which could limit financial flexibility. The company's liquidity risk is rated as medium, and while dilution risk is low, the absence of a clear capital allocation strategy could lead to suboptimal returns. The risk assessment also highlights the need for improved cash flow generation to support long-term stability. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's latest actual EPS of 104.59 JPY and revenue of 133.59 billion JPY align with analyst expectations, suggesting stable performance without significant surprises.

30-day price · 3199(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyWatahan & Co Ltd
Ticker3199.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Watahan & Co Ltd operates in the Food & Drug Retailing sector, generating revenue primarily through the retail and distribution of food and drug products.

Classification. Watahan is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a confidence level of 0.92.

Watahan maintains a capital structure with a debt-to-equity ratio of 1.15, indicating moderate leverage relative to equity. The company's liquidity position is characterized by a current ratio of 1.26, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of 1.93 billion JPY supports operational flexibility, though operating cash flow is negative at -2.88 billion JPY, signaling potential working capital constraints. Profitability metrics show a return on equity of 8.94% and a return on assets of 2.62%, both below the typical thresholds for high-performing retailers. The company's operating margin is 2.15% (2.87 billion JPY operating income on 133.59 billion JPY revenue), which is weak compared to industry peers. Gross margin of 21.0% (28.03 billion JPY gross profit) is in line with the sector median, but the low operating margin suggests high operating expenses or pricing pressures. Geographically, Watahan's revenue is concentrated in Japan, with no disclosed international operations. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or customer bases. This concentration increases exposure to domestic economic shifts and regulatory changes. The company's growth trajectory is modest, with revenue of 133.59 billion JPY in the latest period. No forward-looking guidance is provided, but the current price-to-earnings ratio of 12.41 and price-to-book of 1.11 suggest a valuation in line with industry norms. The enterprise value to EBITDA of 16.93 is also consistent with the sector average, indicating a stable but not aggressive growth profile. Risk factors include a negative net cash position after subtracting total debt, which could limit financial flexibility. The company's liquidity risk is rated as medium, and while dilution risk is low, the absence of a clear capital allocation strategy could lead to suboptimal returns. The risk assessment also highlights the need for improved cash flow generation to support long-term stability. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's latest actual EPS of 104.59 JPY and revenue of 133.59 billion JPY align with analyst expectations, suggesting stable performance without significant surprises.
Key takeaways
  • Watahan's debt-to-equity ratio of 1.15 and negative operating cash flow highlight moderate leverage and liquidity risks.
  • The company's return on equity of 8.94% is below the sector median, indicating suboptimal capital efficiency.
  • Revenue is concentrated in Japan, with no international diversification, increasing exposure to domestic economic conditions.
  • The valuation multiples (P/E of 12.41, EV/EBITDA of 16.93) are in line with industry norms, suggesting a stable but not aggressive growth profile.
  • The company's liquidity risk is rated as medium, and the absence of a clear capital allocation strategy could impact long-term returns.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$133.59B
Gross profit$28.03B
Operating income$2.87B
Net income$2.08B
R&D
SG&A
D&A
SBC
Operating cash flow-$2.88B
CapEx-$1.82B
Free cash flow$1.93B
Total assets$79.43B
Total liabilities$56.19B
Total equity$23.24B
Cash & equivalents$3.96B
Long-term debt$26.68B
Valuation
Market price$1380.00
Market cap$25.79B
Enterprise value$48.51B
P/E12.4
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income16.9
EV/OCF
P/B1.1
P/Tangible book1.1
Tangible book$23.24B
Net cash-$22.72B
Current ratio1.3
Debt/Equity1.1
ROA2.6%
ROE8.9%
Cash conversion-1.4%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
Metric3199Activity
Op margin2.1%2.8% medp25 0.9% · p75 5.9%below median
Net margin1.6%1.8% medp25 0.3% · p75 3.6%below median
Gross margin21.0%24.1% medp25 13.8% · p75 31.4%below median
CapEx / revenue-1.4%-2.0% medp25 -3.8% · p75 -1.0%above median
Debt / equity115.0%56.0% medp25 14.0% · p75 113.8%top quartile
Observations
IR observations
Last actual EPS104.59 JPY
Last actual revenue133,594,000,000 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-22 05:44 UTCJob: 558c7c6d